These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6766335)

  • 1. Polybrene-induced platelet agglutination and reduction in electrophoretic mobility: enhancement by von Willebrand factor and inhibition by vancomycin.
    Coller BS
    Blood; 1980 Feb; 55(2):276-81. PubMed ID: 6766335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botrocetin- and polybrene-induced platelet aggregation in platelet-type von Willebrand disease.
    Takahashi H; Nagayama R; Hattori A; Shibata A
    Am J Hematol; 1985 Feb; 18(2):179-89. PubMed ID: 3871585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
    Coller BS
    J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor, polycations, and platelet agglutination.
    Rosborough TK
    Thromb Res; 1980 Feb 1-15; 17(3-4):481-90. PubMed ID: 6966084
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal polybrene-induced platelet agglutination in von Willebrand's disease.
    Rosborough TK; Swaim WR
    Thromb Res; 1978 May; 12(5):937-42. PubMed ID: 307834
    [No Abstract]   [Full Text] [Related]  

  • 6. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ristocetin-induced platelet agglutination by vancomycin.
    Moake JL; Cimo PL; Peterson DM; Roper P; Natelson EA
    Blood; 1977 Sep; 50(3):397-406. PubMed ID: 301760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin.
    Coller BS; Gralnick HR
    J Clin Invest; 1977 Aug; 60(2):302-12. PubMed ID: 17620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to human factor VIII/von Willebrand factor inhibits collagen-induced platelet aggregation and release.
    Tschopp TB; Baumgartner HR; Meyer D
    Thromb Res; 1980 Jan 1-15; 17(1-2):255-9. PubMed ID: 6769178
    [No Abstract]   [Full Text] [Related]  

  • 11. Species specificity in von Willebrand factor-supported platelet agglutination.
    Johnson GS; Dodds WJ; Rosborough TK
    Ann N Y Acad Sci; 1981; 370():227-35. PubMed ID: 6973945
    [No Abstract]   [Full Text] [Related]  

  • 12. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Feb 1-15; 17(3-4):443-52. PubMed ID: 6966083
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of inhibition by trinitrophenylation of the ristocetin cofactor activity of von Willebrand factor.
    Santoro SA; Cowan JF
    Biochim Biophys Acta; 1984 Feb; 797(2):178-85. PubMed ID: 6607747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
    Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA
    Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The agglutination of human platelets by bovine factor VIII: R.
    Kirby EP
    J Lab Clin Med; 1982 Dec; 100(6):963-76. PubMed ID: 6183384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
    Moore A; Ross GD; Nachman RL
    J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
    Levine SP; Moake JL
    Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB; Puszkin EG; Sussman II; Mauss EA
    J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.